2024-03-01 2025-02-28 false No description of principal activity Capium Accounts Production 1.1 13931633 2024-03-01 2025-02-28 13931633 bus:FullAccounts 2024-03-01 2025-02-28 13931633 bus:FRS102 2024-03-01 2025-02-28 13931633 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 13931633 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 13931633 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 13931633 2024-03-01 2025-02-28 13931633 2025-02-28 13931633 bus:RegisteredOffice 2024-03-01 2025-02-28 13931633 core:WithinOneYear 2025-02-28 13931633 core:AfterOneYear 2025-02-28 13931633 1 2024-03-01 2025-02-28 13931633 bus:Director1 2024-03-01 2025-02-28 13931633 bus:Director1 2025-02-28 13931633 bus:Director1 2023-03-01 2024-02-29 13931633 bus:Director2 2024-03-01 2025-02-28 13931633 bus:Director2 2025-02-28 13931633 bus:Director2 2023-03-01 2024-02-29 13931633 2023-03-01 13931633 bus:CompanySecretary1 2024-03-01 2025-02-28 13931633 bus:LeadAgentIfApplicable 2024-03-01 2025-02-28 13931633 2023-03-01 2024-02-29 13931633 2024-02-29 13931633 core:WithinOneYear 2024-02-29 13931633 core:AfterOneYear 2024-02-29 13931633 bus:EntityAccountantsOrAuditors 2023-03-01 2024-02-29 13931633 bus:OrdinaryShareClass1 2024-03-01 2025-02-28 13931633 bus:OrdinaryShareClass1 2025-02-28 13931633 bus:OrdinaryShareClass1 2023-03-01 2024-02-29 13931633 bus:OrdinaryShareClass1 2024-02-29 13931633 core:ComputerEquipment 2024-03-01 2025-02-28 13931633 core:ComputerEquipment 2025-02-28 13931633 core:ComputerEquipment 2024-02-29 13931633 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-02-28 13931633 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-02-29 13931633 core:CostValuation core:Non-currentFinancialInstruments 2025-02-28 13931633 core:CostValuation core:Non-currentFinancialInstruments 2024-02-29 13931633 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-02-28 13931633 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-02-28 13931633 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-02-28 13931633 core:Non-currentFinancialInstruments 2025-02-28 13931633 core:Non-currentFinancialInstruments 2024-02-29 13931633 core:ShareCapital 2025-02-28 13931633 core:ShareCapital 2024-02-29 13931633 core:RetainedEarningsAccumulatedLosses 2025-02-28 13931633 core:RetainedEarningsAccumulatedLosses 2024-02-29 13931633 dpl:Item1 2024-03-01 13931633 dpl:Item1 2025-02-28 13931633 dpl:Item1 2023-03-01 13931633 dpl:Item1 2024-02-29 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 13931633
England and Wales

 

 

 


Unaudited Financial Statements


for the year ended 28 February 2025

for

STOLADY MEDICAL SERVICES LTD

 
 
Notes
 
2025
£
  2024
£
Fixed assets      
Tangible fixed assets 3 1,661    1,646 
1,661    1,646 
Current assets      
Debtors 4 1,499    2,626 
Cash at bank and in hand 17,432    16,349 
18,931    18,975 
Creditors: amount falling due within one year 5 (13,334)   (18,622)
Net current assets 5,597    353 
 
Total assets less current liabilities 7,258    1,999 
Provisions for liabilities 6 (416)   (412)
Net assets 6,842    1,587 
 

Capital and reserves
     
Called up share capital 7 100    100 
Profit and loss account 6,742    1,487 
Shareholders' funds 6,842    1,587 
 


For the year ended 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 13 May 2025 and were signed on its behalf by:


-------------------------------
Daniel Stolady
Director
1
General Information
STOLADY MEDICAL SERVICES LTD is a private company, limited by shares, registered in England and Wales, registration number 13931633, registration address 13 The Close, Norwich, Norfolk, NR1 4DS.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment 33% Straight Line
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average number of employees

1
Average number of employees during the year was 1 (2024 : 1).
3.

Tangible fixed assets

Cost or valuation Computer Equipment   Total
  £   £
At 01 March 2024 2,375    2,375 
Additions 1,077    1,077 
Disposals  
At 28 February 2025 3,452    3,452 
Depreciation
At 01 March 2024 729    729 
Charge for year 1,062    1,062 
On disposals  
At 28 February 2025 1,791    1,791 
Net book values
Closing balance as at 28 February 2025 1,661    1,661 
Opening balance as at 01 March 2024 1,646    1,646 


4.

Debtors: amounts falling due within one year

2025
£
  2024
£
Trade Debtors 1,499    2,626 
1,499    2,626 

5.

Creditors: amount falling due within one year

2025
£
  2024
£
Corporation Tax 5,687    2,055 
PAYE & Social Security 140   
Wages & Salaries Control Account 560   
Directors' Current Accounts 6,947    16,567 
13,334    18,622 

6.

Provisions for liabilities

2025
£
  2024
£
Deferred Tax 412   
Charged to Profit & Loss   412 
416    412 

7.

Share Capital

Authorised
100 Class A shares of £1.00 each
Allotted, called up and fully paid
2025
£
  2024
£
100 Class A shares of £1.00 each 100    100 
100    100 

2